Evidence map›Paper›PMID 18046413›Full record

ArticleNature2007

Calcineurin sets the bandwidth for discrimination of signals during thymocyte development.

Elena M Gallo, Monte M Winslow, Kirsten Canté-Barrett, Amy N Radermacher, Lena Ho, Lisa McGinnis, Brian Iritani, Joel R Neilson, Gerald R Crabtree

Open access · greenAbstract read
In one paragraph

Article in Nature, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. CaInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Elena M GalloHoward Hughes Medical Institute and the Department of Pathology, Stanford University, Stanford, California 94305, USA.
Monte M Winslow
Kirsten Canté-Barrett
Amy N Radermacher
Lena Ho
Lisa McGinnis
Brian Iritani
Joel R Neilson
Gerald R Crabtree
Howard Hughes Medical Institute · USStanford University · USUniversity of Washington · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Control of T Lymphopoiesis and Growth by Mad GenesR01AI053568 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2003 to 2007
$1.5M
Investigation of Myc Oncoprotein in B lymphocyte Development and TransformationK26RR024462 · NCRR · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2008 to 2011
$446k
ROLE OF P21 RAS IN B LYMPHOPOIESISK08AI001445 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 1997 to 2001
$241k
Investigation of Myc Oncoprotein in B lymphocyte Development and TransformationK26OD011060 · OD · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2012 to 2012
$115k
NCRR NIH HHS K26 RR024462NIAID NIH HHS R01 AI053568NIAID NIH HHS T32 AI007290NIH HHS K26 OD011060
6 · The paper itself

Abstract

At critical times in development, cells are able to convert graded signals into discrete developmental outcomes; however, the mechanisms involved are poorly understood. During thymocyte development, cell fate is determined by signals originating from the alphabeta T-cell receptor. Low-affinity/avidity interactions between the T-cell receptor and peptide-MHC complexes direct differentiation to the single-positive stage (positive selection), whereas high-affinity/avidity interactions induce death by apoptosis (negative selection). Here we show that mice deficient in both calcineurin and nuclear factor of activated T cells (NFAT)c2/c3 lack a population of preselection thymocytes with enhanced ability to activate the mitogen-activated protein kinase (Raf-MEK-ERK) pathway, and fail to undergo positive selection. This defect can be partially rescued with constitutively active Raf, indicating that calcineurin controls MAPK signalling. Analysis of mice deficient in both Bim (which is required for negative selection) and calcineurin revealed that calcineurin-induced ERK (extracellular signal-regulated kinase) sensitization is required for differentiation in response to 'weak' positive selecting signals but not in response to 'strong' negative selecting signals (which normally induce apoptosis). These results indicate that early calcineurin/NFAT signalling produces a developmental period of ERK hypersensitivity, allowing very weak signals to induce positive selection. This mechanism might be generally useful in the discrimination of graded signals that induce different cell fates.

Indexed as

Cell DifferentiationMAP Kinase Signaling SystemAmino Acid SequenceAnimalsApoptosis Regulatory ProteinsBcl-2-Like Protein 11CalcineurinCells, CulturedEnzyme ActivationExtracellular Signal-Regulated MAP KinasesLigandsMembrane ProteinsMiceMitogen-Activated Protein Kinase KinasesNFATC Transcription FactorsProto-Oncogene ProteinsApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11CalcineurinExtracellular Signal-Regulated MAP KinasesLigandsMembrane ProteinsMitogen-Activated Protein Kinase KinasesNFATC Transcription FactorsProto-Oncogene Proteinsraf KinasesReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID18046413
PMCPMC5336393
OpenAlexW2083148444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.